Differential prognostic importance of QRS duration in heart failure and acute myocardial infarction associated with left ventricular dysfunction

European Journal of Heart Failure

Volumn 9, Issue 8, 2007, Pages 814-819

  Fosbøl, Emil Loldrup ^a   Seibæk, Marie ^c   Brendorp, Bente ^a   Møller, Daniél Vega ^a   Ersbøll, Mads ^a   Torp Pedersen, Christian ^b   Køber, Lars ^a  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myocardial infarction; Heart failure; Left ventricular dysfunction; Prognosis; QRS duration

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34547670281     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.04.005     Document Type: Article

References (25)

1. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 15 (2005) 1539-1549
2. Shamim W., Yousufuddin M., Cicoria M., Gibson D.G., Coats A.J., and Henein M.Y. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 88 1 (2002) 47-51
3. Kalra P.R., Sharma R., Shamim W., et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 86 2-3 (2002) 225-231
4. Iuliano S., Fisher S.G., Karasik P.E., Fletcher R.D., and Singh S.N. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 6 (2002) 1085-1091
5. Baldasseroni S., Gentile A., Gorini M., et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 4 9 (2003) 607-613
6. Silverman M.E., Pressel M.D., Brackett J.C., Lauria S.S., Gold M.R., and Gottlieb S.S. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 75 7 (1995) 460-464
7. Shenkman H.J., Pampati V., Khandelwal A.K., et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest 122 2 (2002) 528-534
8. Pudil R., Feinberg M.S., Hod H., Boyko V., Mandelzweig L., and Behar S. The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int J Cardiol 78 3 (2001) 233-239
9. Hathaway W.R., Peterson E.D., Wagner G.S., et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA 279 5 (1998) 387-391
10. Brilakis E.S., Mavrogiorgos N.C., Kopecky S.L., et al. Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol 89 9 (2002) 1013-1018
11. Elhendy A., Hammill S.C., Mahoney D.W., and Pellikka P.A. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 96 8 (2005) 1082-1088
12. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341 12 (1999) 857-865
13. Kober L., Bloch Thomsen P.E., Moller M., et al. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 356 9247 (2000) 2052-2058
14. Silvet H., Amin J., Padmanabhan S., and Pai R.G. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. Am J Cardiol 88 2 (2001) 182-185 [A6]
15. Kashani A., and Barold S.S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46 12 (2005) 2183-2192
16. Stenestrand U., Tabrizi F., Lindback J., Englund A., Rosenqvist M., and Wallentin L. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation 110 14 (2004) 1896-1902
17. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 3 (2006) 251-259
18. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 3 (2006) 260-269
19. Rivero-Ayerza M., Theuns D.A., Garcia-Garcia H.M., Boersma E., Simoons M., and Jordaens L.J. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27 22 (2006) 2682-2688
20. Sanderson J.E. QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence? Reply. Eur Heart J 27 24 (2006) 3075
21. Sanderson J.E. Assessment of ventricular dyssynchrony: global or regional function?. Eur Heart J 27 20 (2006) 2380-2381
22. Hawkins N.M., Petrie M.C., Macdonald M.R., Hogg K.J., and McMurray J.J. QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?. Eur Heart J 27 24 (2006) 3074-3075 [author reply 3075]
23. Hawkins N.M., Petrie M.C., MacDonald M.R., Hogg K.J., and McMurray J.J. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?. Eur Heart J 27 11 (2006) 1270-1281
24. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 12 (2002) 877-883
25. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237